血浆原纤维蛋白-1水平在自发性脑动脉夹层患者中的价值
单中心前瞻性队列纳入99例自发性脑动脉夹层患者,按年龄性别匹配115例非夹层缺血性卒中患者和20名健康体检者,用ELISA检测血浆原纤维蛋白-1。夹层组均值85.56 ng/mL高于非夹层卒中组77.13 ng/mL和健康对照组73.04 ng/mL,急性期差异最明显;基线水平较低者随访影像形态学恢复更好。
要点
- 夹层组血浆原纤维蛋白-1均值85.56 ng/mL,高于非夹层卒中组77.13 ng/mL和健康对照组73.04 ng/mL。
- 急性期夹层组97.64 ng/mL,非夹层卒中组74.39 ng/mL,健康对照组73.04 ng/mL。
- 以88.455 ng/mL为界值区分急性夹层与非夹层卒中,敏感度0.778、特异度0.800。
核心结论
- 血浆原纤维蛋白-1是有望辅助诊断急性自发性脑动脉夹层的生物标志物,并可能在病变严重程度分级和影像学预后预测方面具有潜在价值。
- 本研究提供III级证据表明自发性脑动脉夹层患者的血浆原纤维蛋白-1水平显著高于因其他原因所致缺血性卒中患者。
研究设计与样本
- 单中心前瞻性队列,2013年2月至2015年12月连续纳入99例自发性脑动脉夹层患者,按年龄和性别匹配115例非夹层缺血性卒中患者及20名常规体检健康者。
- 采用ELISA检测血浆原纤维蛋白-1水平并在三组间比较,分析其与夹层部位、急性期及严重程度以及临床和影像学预后的关联。
主要发现
- 夹层组血浆原纤维蛋白-1均值85.56 ng/mL(95%CI 81.53-89.59),高于非夹层缺血性卒中组77.13 ng/mL(95%CI 73.64-80.63,p=0.015)和健康对照组73.04 ng/mL(95%CI 65.94-80.13,p=0.029)。
- 急性期差异最明显:夹层组97.64 ng/mL(95%CI 91.64-103.64),非夹层卒中组74.39 ng/mL(95%CI 68.95-79.84),健康对照组73.04 ng/mL(95%CI 65.95-80.13)。
- 以88.455 ng/mL为界值区分急性夹层与非夹层卒中,敏感度0.778、特异度0.800。
- 影像学上夹层更严重的患者原纤维蛋白-1水平更高(p<0.001),基线原纤维蛋白-1浓度较低者在随访影像检查中形态学恢复更好(p=0.003)。
关键数值与推荐
- 夹层组血浆原纤维蛋白-1均值85.56 ng/mL(95%CI 81.53-89.59)。
- 非夹层缺血性卒中组77.13 ng/mL(95%CI 73.64-80.63),健康对照组73.04 ng/mL(95%CI 65.94-80.13)。
- 急性期夹层组97.64 ng/mL(95%CI 91.64-103.64),非夹层卒中组74.39 ng/mL(95%CI 68.95-79.84),健康对照组73.04 ng/mL(95%CI 65.95-80.13)。
- 区分急性夹层与非夹层卒中的界值88.455 ng/mL,敏感度0.778、特异度0.800。
临床怎么用
- 原文结论认为血浆原纤维蛋白-1是有望辅助诊断急性自发性脑动脉夹层的生物标志物,并可能在病变严重程度分级和影像学预后预测方面具有潜在价值。
- 本研究提供III级证据表明自发性脑动脉夹层患者血浆原纤维蛋白-1水平显著高于因其他原因所致缺血性卒中患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore the value of plasma fibrillin-1 levels in patients with spontaneous cerebral artery dissection (sCeAD). METHODS: A single-center prospective cohort of 99 consecutive patients with sCeAD between February 2013 and December 2015 were age and sex matched with 115 patients with non-sCeAD ischemic stroke and 20 healthy participants undergoing routine physical examination. The plasma fibrillin-1 level was measured with ELISA and compared among the 3 groups. The associations of fibrillin-1 with site, acuity, and severity of dissection, as well as clinical and radiographic prognosis of patients, were analyzed. RESULTS: One hundred nine plasma samples from 99 patients with sCeAD, 115 from disease control patients, and 20 from healthy participants were collected. The plasma fibrillin-1 level of the dissection group (mean 85.56 ng/mL [95% confidence interval 81.53-89.59]) was higher than that of non-sCeAD ischemic stroke group (77.13 ng/mL [73.64-80.63], p = 0.015) or healthy controls (73.04 ng/mL [65.94-80.13], p = 0.029). Such differences were most prominent in the acute stage (97.64 ng/mL [91.64-103.64], 74.39 ng/mL [68.95-79.84], and 73.04 ng/mL [65.95-80.13], respectively). A cutoff value of 88.455 ng/mL was determined to differentiate acute dissection from nondissection stroke with a sensitivity of 0.778 and a specificity of 0.800. Higher fibrillin-1 level was detected in patients with more severe dissection radiographically (p < 0.001), while patients with lower fibrillin-1 concentration at baseline achieved better morphologic recovery on follow-up imaging tests (p = 0.003). CONCLUSION: Plasma fibrillin-1 is a promising biomarker for aiding the diagnosis of acute sCeAD and may have potential value in lesion severity grading and radiographic prognosis prediction. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that patients with sCeAD have significantly higher levels of plasma fibrillin-1 than patients with ischemic stroke attributable to a cause other than sCeAD.
引用
- Zhu Z, Tang W, Ge L, et al. The value of plasma fibrillin-1 level in patients with spontaneous cerebral artery dissection. Neurology. 2018. PMID: 29386281. doi:10.1212/WNL.0000000000005027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。